These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18617866)

  • 1. The safety of the electroconvulsive therapy-escitalopram combination.
    Masdrakis VG; Oulis P; Florakis A; Valamoutopoulos T; Markatou M; Papadimitriou GN
    J ECT; 2008 Dec; 24(4):289-91. PubMed ID: 18617866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin syndrome after electroconvulsive therapy in a patient on trazodone, bupropion, and quetiapine: a case report.
    Cheng YC; Liang CM; Liu HC
    Clin Neuropharmacol; 2015; 38(3):112-3. PubMed ID: 25970280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy for an urgent social indication.
    Kellner CH; Tobias KG; Jakubowski LM; Ali Z; Istafanous RM
    J ECT; 2009 Dec; 25(4):274-5. PubMed ID: 19455061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for the efficacy of electroconvulsive therapy: chart review of a naturalistic study.
    Kho KH; Zwinderman AH; Blansjaar BA
    J Clin Psychiatry; 2005 Jul; 66(7):894-9. PubMed ID: 16013905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of the electroconvulsive therapy-aripiprazole combination: four case reports.
    Masdrakis VG; Oulis P; Zervas IM; Karakatsanis NA; Kouzoupis AV; Karapoulios E; Soldatos CR
    J ECT; 2008 Sep; 24(3):236-8. PubMed ID: 18562946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomania induced by escitalopram: 2 case reports.
    Sharma RC
    Psychopharmacol Bull; 2009; 42(2):89-91. PubMed ID: 19629025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexamining the Role of Electroconvulsive Therapy in Anorexia Nervosa in Adolescents.
    Andersen L; LaRosa C; Gih DE
    J ECT; 2017 Dec; 33(4):294-296. PubMed ID: 28471772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hyponatremia associated with escitalopram.
    Nahshoni E; Weizman A; Shefet D; Pik N
    J Clin Psychiatry; 2004 Dec; 65(12):1722. PubMed ID: 15641882
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined use of ECT with duloxetine and olanzapine: a case report.
    Hanretta AT; Malek-Ahmadi P
    J ECT; 2006 Jun; 22(2):139-41. PubMed ID: 16801831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-associated mania with escitalopram.
    Prapotnik M; Di Pauli J; Vetter Z; König P; Conca A; Waschgler R
    Eur Psychiatry; 2004 Nov; 19(7):455-6. PubMed ID: 15504660
    [No Abstract]   [Full Text] [Related]  

  • 13. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
    Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
    J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.
    Abdallah CG; Fasula M; Kelmendi B; Sanacora G; Ostroff R
    J ECT; 2012 Sep; 28(3):157-61. PubMed ID: 22847373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany.
    Möller HJ; Schnitker J; Flürenbrock W
    Pharmacopsychiatry; 2010 Aug; 43(6):210-5. PubMed ID: 20589597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram: a review of its use in the management of major depressive disorder in adults.
    Garnock-Jones KP; McCormack PL
    CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agomelatine reversal of escitalopram-induced apathy: a case report.
    De Berardis D; Valchera A; Fornaro M; Serroni N; Marini S; Moschetta FS; Martinotti G; Di Giannantonio M
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):190-1. PubMed ID: 23581873
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.